1.27
price down icon3.79%   -0.05
after-market アフターアワーズ: 1.27
loading
前日終値:
$1.32
開ける:
$1.32
24時間の取引高:
72,396
Relative Volume:
0.67
時価総額:
$13.76M
収益:
-
当期純損益:
$-30.15M
株価収益率:
-2.2281
EPS:
-0.57
ネットキャッシュフロー:
$-21.66M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-17.53%
6か月 パフォーマンス:
-39.52%
1年 パフォーマンス:
-61.23%
1日の値動き範囲:
Value
$1.27
$1.35
1週間の範囲:
Value
$1.2278
$1.45
52週間の値動き範囲:
Value
$1.10
$7.333

Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile

Name
名前
Nrx Pharmaceuticals Inc
Name
セクター
Healthcare (1182)
Name
電話
484-254-6134
Name
住所
1201 ORANGE STREET, WILMINGTON
Name
職員
0
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
NRXP's Discussions on Twitter

Nrx Pharmaceuticals Inc (NRXP) 最新ニュース

pulisher
Nov 01, 2024

NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update L - GuruFocus.com

Nov 01, 2024
pulisher
Oct 31, 2024

NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule - GlobeNewswire

Oct 31, 2024
pulisher
Oct 30, 2024

NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq th - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry Clinics - StockTitan

Oct 30, 2024
pulisher
Oct 29, 2024

NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Unde - GuruFocus.com

Oct 29, 2024
pulisher
Oct 26, 2024

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024 - GuruFocus.com

Oct 26, 2024
pulisher
Oct 26, 2024

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Second Quarte - GuruFocus.com

Oct 26, 2024
pulisher
Oct 26, 2024

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2 - GuruFocus.com

Oct 26, 2024
pulisher
Oct 24, 2024

NRx Pharmaceuticals, Inc. and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024 - Marketscreener.com

Oct 24, 2024
pulisher
Oct 23, 2024

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE - GlobeNewswire

Oct 23, 2024
pulisher
Oct 23, 2024

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024 - StockTitan

Oct 23, 2024
pulisher
Oct 23, 2024

EF Hutton Acquisition Co. I Upgrades NRx Pharmaceuticals (NASDAQ:NRXP) to Strong-Buy - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

Can Nrx combination unlock NMDA’s oomph in akathisia? - BioWorld Online

Oct 22, 2024
pulisher
Oct 21, 2024

EF Hutton sets stock target on NRx Pharma, cites suicide prevention - Investing.com India

Oct 21, 2024
pulisher
Oct 21, 2024

NRx started at buy by EF Hutton, cites suicide prevention focus - MSN

Oct 21, 2024
pulisher
Oct 21, 2024

NRx started at buy by EF Hutton, cites suicide prevention focus (NASDAQ:NRXP) - Seeking Alpha

Oct 21, 2024
pulisher
Oct 16, 2024

NRx Pharmaceuticals secures additional $5 million funding By Investing.com - Investing.com Nigeria

Oct 16, 2024
pulisher
Oct 15, 2024

NRx Pharmaceuticals secures additional $5 million funding - Investing.com India

Oct 15, 2024
pulisher
Oct 14, 2024

NRx Pharmaceuticals announces CEO resignation and stockholder votes - Investing.com

Oct 14, 2024
pulisher
Oct 14, 2024

NRx Pharmaceuticals announces CEO resignation and stockholder votes By Investing.com - Investing.com Canada

Oct 14, 2024
pulisher
Oct 12, 2024

NRx Pharmaceuticals Leadership Shift and Strategic Governance Decisions - Yahoo Finance

Oct 12, 2024
pulisher
Oct 11, 2024

NRx Pharmaceuticals, Inc. Announces Chief Executive Officer Changes - Marketscreener.com

Oct 11, 2024
pulisher
Oct 10, 2024

NRXP stock touches 52-week low at $1.33 amid market challenges - Investing.com

Oct 10, 2024
pulisher
Oct 09, 2024

NRx Pharmaceuticals, Inc. announced that it has received $10 million in funding from Streeterville Capital, LLC - Marketscreener.com

Oct 09, 2024
pulisher
Oct 07, 2024

NRx Pharmaceuticals Advances Towards FDA Approval with Key Stability Milestone for NRX-100 - MSN

Oct 07, 2024
pulisher
Oct 03, 2024

HOPE Therapeutics and NRx Pharmaceuticals to Acquire a Premier West Coast Interventional Psychiatric Clinic - citybiz

Oct 03, 2024
pulisher
Oct 03, 2024

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic - cnhinews.com

Oct 03, 2024
pulisher
Oct 03, 2024

NRXP stock touches 52-week low at $1.59 amid market challenges - Investing.com Australia

Oct 03, 2024
pulisher
Oct 02, 2024

NRXP stock touches 52-week low at $1.59 amid market challenges By Investing.com - Investing.com South Africa

Oct 02, 2024
pulisher
Oct 02, 2024

Verrica Pharmaceuticals Streamlines Operations to Enhance YCANTH Access - MyChesCo

Oct 02, 2024
pulisher
Oct 01, 2024

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine) - The Malaysian Reserve

Oct 01, 2024
pulisher
Sep 30, 2024

NRx reports stable ketamine for suicidal depression treatment By Investing.com - Investing.com Australia

Sep 30, 2024
pulisher
Sep 30, 2024

NRX-100 (Ketamine) Reaches Stability Milestone - Contract Pharma

Sep 30, 2024
pulisher
Sep 30, 2024

NRx reports stable ketamine for suicidal depression treatment - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

NRx Pharmaceuticals Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine) - citybiz

Sep 30, 2024
pulisher
Sep 20, 2024

NRx Pharmaceuticals Featured on Psychiatrist.com - citybiz

Sep 20, 2024
pulisher
Sep 18, 2024

Neumora Therapeutics (NASDAQ:NMRA) Stock Price Up 5.2% - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Energy Vault Holdings Inc (NRGV) expanding its growth trajectory ahead - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

Market Insights: Recursion Pharmaceuticals Inc (RXRX)’s Notable Gain of 1.65, Closing at 6.76 - The Dwinnex

Sep 18, 2024
pulisher
Sep 18, 2024

Rocket Pharmaceuticals’ (RCKT) Buy Rating Reaffirmed at Needham & Company LLC - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

The Significance of Moving Averages in Recursion Pharmaceuticals Inc Inc. (RXRX) Price Performance - The InvestChronicle

Sep 17, 2024
pulisher
Sep 17, 2024

Meeder Advisory Services Inc. Increases Stake in Royalty Pharma plc (NASDAQ:RPRX) - Defense World

Sep 17, 2024
pulisher
Sep 17, 2024

Market Update: Energy Vault Holdings Inc (NRGV) Sees Negative Movement, Closing at 0.79 - The Dwinnex

Sep 17, 2024
pulisher
Sep 17, 2024

NRx Pharmaceuticals’ Innovative Treatments for Depression Gain Spotlight - MSN

Sep 17, 2024
pulisher
Sep 17, 2024

Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by State of New Jersey Common Pension Fund D - Defense World

Sep 17, 2024
pulisher
Sep 16, 2024

Reneo Pharmaceuticals Inc (RPHM) rating downgrades by Leerink Partners - Knox Daily

Sep 16, 2024
pulisher
Sep 16, 2024

Reneo Pharmaceuticals executive buys shares worth over $484k By Investing.com - Investing.com Canada

Sep 16, 2024
pulisher
Sep 16, 2024

Recursion Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily

Sep 16, 2024

Nrx Pharmaceuticals Inc (NRXP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):